Home / Market News / $SRZN

$SRZN news and market catalysts

The 3 most recent market catalysts affecting $SRZN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

3 catalysts 0 high impact 2 bullish 0 bearish Biotechnology
Sep 25, 2026 Corporate Catalyst Bullish Impact 65
HC Wainwright & Co. Maintains Buy on Surrozen, Raises Price Target to $54
HC Wainwright & Co. analyst Matthew Caufield has maintained a 'Buy' rating on Surrozen (SRZN) and raised the price target from $44 to $54. This upgrade in price target indicates in…
Sep 24, 2026 Corporate Catalyst Bullish Impact 75
Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy
Surrozen Inc. announced the submission of an Investigational New Drug (IND) application to the FDA for SZN-8141, targeting diabetic macular edema. This is a critical milestone for …
Aug 10, 2026 Corporate Catalyst Neutral Impact 55
HC Wainwright & Co. Reiterates Buy on Surrozen, Maintains $44 Price Target
This 8-K filing discloses that HC Wainwright & Co. analyst Matthew Caufield has reiterated a 'Buy' rating for Surrozen (SRZN) and maintained a $44 price target. This action signals…
 Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.